An ultherapy vs thermage comparison is usually conducted between two premium platform families, which means the buyer is choosing between a specific implementation of ultrasound and a specific implementation of radiofrequency rather than between two technologies in the abstract.
This guide explains what each platform family is, how the mechanisms behave differently, which depths each addresses, what each costs to run, how the courses differ, what the evidence describes and how a buyer or clinic should compare them.
What these two platforms actually are
One is a focused ultrasound platform, the other a radiofrequency one.
Ultherapy is associated with microfocused ultrasound delivered at set depths, while Thermage is associated with radiofrequency energy applied through a cooled applicator.
Both names carry years of clinical use and a reputation built on results, and both have been widely copied by other manufacturers, which is why the names should be read as families rather than as single products.
That distinction matters to a buyer. Comparing a premium platform with a low-cost imitator tells you nothing useful, whereas comparing the two families on depth coverage, consumable economics and support produces a decision you can defend.
It also matters to a client conversation. A practitioner who can say which plane is being treated and why is describing a treatment, while one who recites a brand name is describing a brochure.
Is ultherapy vs thermage a comparison of modalities or brands?
Both: different modalities, specific brands.
The two platforms rely on different physics, and each is also a commercial product with its own cartridge or tip supply, training and service path.
Keeping those two questions separate prevents a common error, which is choosing a platform because the modality sounds more advanced while ignoring what the consumables will cost over three years of use.
The modality answers what the treatment can influence; the brand answers what you will pay to deliver it and who will support you when it fails. A buyer needs both answers, and suppliers tend to be more forthcoming about the first than the second.
For clients, the useful framing is that both approaches produce gradual change and neither is a substitute for the other. Our comparison of HIFU with Ultherapy and of HIFU with Thermage covers each family against the wider modality.
How do the two mechanisms behave differently?
Focal depth versus broader heating through a cooled surface.
Microfocused ultrasound concentrates energy at a chosen plane with little effect above it, while radiofrequency raises temperature across a volume of tissue with surface cooling to protect the skin.
That difference explains how each one is used. A focal approach can be aimed at the plane that matters for a specific area, which makes depth selection the decisive planning decision. A broader heating approach covers a region evenly, which makes applicator choice and operator consistency the decisive factors.
Clinical descriptions of each modality are available in measured language: a published review of radiofrequency technology for skin covers the second, while a peer-reviewed review of safety and efficacy on the ultrasound side describes the first.
Neither mechanism is more advanced. They address tissue differently, and a service list that includes both is coherent rather than redundant.
Which depths does each platform family address?
Depth is explicit on one and indirect on the other.
Ultrasound platforms specify focal depth per cartridge in millimetres, while radiofrequency platforms specify applicators and their intended treatment areas.
Buyers should build the same table for each: what the device can treat, at what depth or with which applicator, and what consumable each treatment consumes. That comparison is possible for both modalities, and it is the only version that supports a purchase decision.
Our guide to reading device specifications shows how to turn those figures into a treatment plan rather than a list of numbers.
Where a supplier cannot state focal depths for an ultrasound platform, or applicator coverage for a radiofrequency one, the specification is incomplete. That gap does not necessarily disqualify the device, but it does mean you cannot plan services around it with any confidence.
What does each platform cost to run?
Cartridges on one, applicator life on the other.
Ultrasound platforms typically meter cost by cartridge shot rating, while radiofrequency platforms meter it by applicator lifespan and any periodic service requirement.
Pricing a treatment properly means converting both into a per-session figure. For cartridges, divide the price by the rating and multiply by the shots your protocol uses. For an applicator, divide its cost by the number of sessions it is rated for and add any service interval cost across the same period.
Then add the support line, which is where cheap platforms become expensive. Ask what spare parts are held for the model, what a replacement handpiece or applicator costs and what the turnaround is, because a device without spares converts a fault into cancelled appointments.
Recording the arithmetic per treatment rather than per device is what keeps a price list honest. Practices that price from an average rather than from their own protocol tend to discover the difference in their margin rather than in their diary.
How do the courses and intervals differ?
Both are courses, spaced according to the response.
Ultrasound protocols are typically spaced weeks apart with a review at a set point, while radiofrequency courses may be more closely grouped depending on the applicator and the objective.
The differences should come from the protocols rather than from the diary. Where spacing is set by convenience, the review measures the schedule rather than the treatment, and a practice loses its ability to compare one client’s course with another’s.
Interval discipline also affects consumable consumption. A tighter course consumes cartridges or applicator life faster, which changes the cost per treatment and therefore the price the service needs to carry.
Recording the interval and the reasoning behind it gives the review something to work with. Our summary of risks and downtime covers what clients should expect after either type of session.
What does the published evidence describe for each?
Gradual change, documented reactions, no superiority claim.
Reviews on both sides report measured improvement over weeks and document the reactions associated with the settings used.
On the radiofrequency side, published work on radiofrequency for skin laxity describes outcomes in clinical terms, and Cleveland Clinic’s page on radiofrequency skin tightening is written for a general audience.
On the ultrasound side, Cleveland Clinic’s description of high-intensity focused ultrasound frames the modality as non-surgical with defined limits, and documented adverse events explain why screening and settings discipline matter.
A comparative study of non-surgical approaches is a useful reference when a client asks how the two families differ, and it is a better source than any brand-versus-brand article.
How should a buyer compare the two platforms?
On coverage, consumables and support.
Those three checks apply to both families and they produce a comparison that still makes sense after a year of ownership.
Start with coverage: list the areas you intend to treat and confirm that each platform can reach them, whether that means cartridges at specific depths or applicators for specific regions. Then price your own protocol on each device, using the consumable arithmetic above.
Finish with support, and treat it as a deciding factor rather than a footnote. A platform with a service path in your country and a parts list is worth more than one with a marginally better specification and no route to repair.
Where the two candidates come out close, the tie-breaker is usually menu fit: which device serves more of the services you already sell, and how many of your current clients would realistically book it. A device that matches observed demand earns its place faster than one that matches a supplier’s forecast, and the same logic applies to which of the two families you buy first if only one is affordable. In that situation a practice should buy the platform whose mechanism covers the largest share of its existing bookings.
How do you match a client to the right platform?
By the concern and the layer it sits in.
Concerns that depend on a specific plane of tissue suit the ultrasound family, while concerns about firmness across a region suit the radiofrequency family.
The assessment should end with a sentence the client can repeat: what is being treated, at which plane or across which area, and what change is expected over what period. If the sentence cannot be formed, the treatment is being chosen by preference rather than by assessment.
Where both are appropriate, the sequence should be planned and recorded rather than offered as a bundle. Clients accept a staged plan more readily than a combined one, and the staged version produces feedback that can actually be attributed to a treatment.
Screening belongs at the same stage, and it is specific to the modality rather than transferable between them. Our comparison of HIFU and RF at the level of the modality covers those differences in more detail.
Documents, prices and a spares commitment.
Three requests, all in writing, separate a supplier who can support a purchase from one who can only complete a sale.
Ask for the specification sheet naming depths or applicator coverage, the price list for consumables with ratings attached, and a written statement of which parts are held and for how long. Where a market requires clearance for the device class, ask for the reference that applies to the exact model and territory as well.
Then ask what happens when the model is superseded. That question is the one most suppliers answer vaguely, and the answer is what determines whether your investment survives the platform’s product cycle.
Keep the replies together with the purchase documents. When a question arises later about a treatment, a reaction or a part, that file is what turns an enquiry into a short email rather than an afternoon of searching.
Platform comparison checklist
Use this list when comparing the two platform families for a purchase.
| Element | What to confirm |
|---|---|
| Coverage | Depths per cartridge or applicators per treatment area |
| Consumables | Shot ratings or applicator lifespans, with prices |
| Per-session cost | Your own protocol, priced on each platform |
| Course structure | Interval pattern, review point and total sessions |
| Support | Spares held, replacement cost and repair turnaround |
| Documentation | Specification sheet and market reference for the model |
Send us the two platforms you are considering with their consumable lists, and we will set out what the comparison should include before you commit. Write to sales@liftwavepro.com.
Conclusion
Ultherapy and Thermage represent two platform families built on different physics: microfocused ultrasound at set depths, and radiofrequency applied through a cooled applicator. Buyers should compare them on coverage, consumable economics and support rather than on reputation, and match clients to the platform whose mechanism suits their concern. The evidence describes gradual change on both sides, with documented reactions on each.
FAQ
Is Ultherapy or Thermage better?
They rely on different mechanisms, so neither is better in general. One concentrates ultrasound at a chosen depth and the other heats a region through a cooled applicator. Which applies depends on your concern and on which layer of tissue it involves.
Do Ultherapy and Thermage do the same thing?
No. One is a focal ultrasound treatment and the other is a radiofrequency treatment, so they act on different tissue in different ways. Both are described in the literature as producing gradual change rather than an immediate result.
Does Thermage hurt more than Ultherapy?
Clients describe the sensations differently rather than ranking them: radiofrequency is often felt as building heat, while focused ultrasound is frequently described as warmth with brief sharper moments at depth. Sensation varies by area and setting on both.
Can a clinic offer both?
Many do, and the pairing is coherent because the two mechanisms address different tissue. It does require training on both and a clear plan for which service is recommended when, since running two platforms doubles the consumable and support burden.